618 related articles for article (PubMed ID: 8826938)
1. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigens and liver metastasis in colorectal cancer.
Hasegawa H; Watanabe M; Arisawa Y; Teramoto T; Kodaira S; Kitajima M
Jpn J Clin Oncol; 1993 Dec; 23(6):336-41. PubMed ID: 7904324
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of sialyl Lewis A and sialyl Lewis X in liver metastases of human colorectal carcinoma.
Yamada N; Chung YS; Maeda K; Sawada T; Ikehara T; Nishino H; Okuno M; Sowa M
Invasion Metastasis; 1995; 15(3-4):95-102. PubMed ID: 8621274
[TBL] [Abstract][Full Text] [Related]
4. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
5. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.
Matsushita Y; Cleary KR; Ota DM; Hoff SD; Irimura T
Lab Invest; 1990 Dec; 63(6):780-91. PubMed ID: 1979361
[TBL] [Abstract][Full Text] [Related]
6. Sialyl Lewisa expression as a predictor of the prognosis of colon carcinoma patients in a prospective randomized clinical trial.
Matsui T; Kojima H; Suzuki H; Hamajima H; Nakazato H; Ito K; Nakao A; Sakamoto J
Jpn J Clin Oncol; 2004 Oct; 34(10):588-93. PubMed ID: 15591456
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis.
Kaihara T; Kusaka T; Nishi M; Kawamata H; Imura J; Kitajima K; Itoh-Minami R; Aoyama N; Kasuga M; Oda Y; Hattori M; Fujimori T
J Exp Clin Cancer Res; 2003 Mar; 22(1):117-23. PubMed ID: 12725331
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
[TBL] [Abstract][Full Text] [Related]
9. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of sialyl Lex expression in human gallbladder carcinoma.
Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Imaizumi T; Makuuchi H
Oncol Rep; 2004 Jun; 11(6):1139-43. PubMed ID: 15138547
[TBL] [Abstract][Full Text] [Related]
12. Sialyl Lewis X expression in vascular permeating lesions as a factor for predicting colorectal cancer metastasis.
Tanaka K; Togo S; Nanko M; Ishikawa T; Ichikawa Y; Yamaoka H; Shimada H
Hepatogastroenterology; 1999; 46(26):875-82. PubMed ID: 10370631
[TBL] [Abstract][Full Text] [Related]
13. Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues.
Tsuboi K; Asao T; Ide M; Hashimoto S; Noguchi K; Kominato Y; Saniabadi AR; Kuwano H; Yazawa S
Ann Surg Oncol; 2007 Jun; 14(6):1880-9. PubMed ID: 17375356
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
[TBL] [Abstract][Full Text] [Related]
15. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome is an important factor for the evolution of prognosis of colorectal cancer: survival, recurrence, and liver metastasis.
Shen Z; Ye Y; Bin L; Yin M; Yang X; Jiang K; Wang S
Am J Surg; 2010 Jul; 200(1):59-63. PubMed ID: 20074697
[TBL] [Abstract][Full Text] [Related]
17. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
18. [Expression of c-erbB-2 protein and vessel invasion in colorectal cancer].
Yamaguchi S; Ohki S; Jo T; Imai S; Matsuo K; Hamahata Y; Fukano M; Tokito S; Hasegawa S; Masui H
Gan To Kagaku Ryoho; 1992 Jan; 19(1):34-9. PubMed ID: 1346087
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
Ogawa M; Ikeuchi K; Watanabe M; Etoh K; Kobayashi T; Takao Y; Anazawa S; Yamazaki Y
Hepatogastroenterology; 2005; 52(63):875-80. PubMed ID: 15966224
[TBL] [Abstract][Full Text] [Related]
20. Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer.
Nakagoe T; Fukushima K; Itoyanagi N; Ikuta Y; Oka T; Nagayasu T; Ayabe H; Hara S; Ishikawa H; Minami H
J Cancer Res Clin Oncol; 2002 May; 128(5):257-64. PubMed ID: 12029441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
